Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference

Allan Lipton; James R. Berenson; Jean Jacques Body; Brendan F. Boyce; Oyvind S. Bruland; Michael A. Carducci; Charles S. Cleeland; Denis R. Clohisy; Robert E. Coleman; Richard J. Cook; Theresa A. Guise; Roger N. Pearse; Trevor J. Powles; Michael J. Rogers; G. David Roodman; Matthew R. Smith; Larry J. Suva; Robert L. Vessella; Katherine N. Weilbaecher; Laura King

doi:10.1158/1078-0432.CCR-06-1213

Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference

Allan Lipton, James R. Berenson, Jean Jacques Body, Brendan F. Boyce, Oyvind S. Bruland, Michael A. Carducci, Charles S. Cleeland, Denis R. Clohisy, Robert E. Coleman, Richard J. Cook, Theresa A. Guise, Roger N. Pearse, Trevor J. Powles, Michael J. Rogers, G. David Roodman, Matthew R. Smith, Larry J. Suva, Robert L. Vessella, Katherine N. Weilbaecher, Laura King

School of Medicine

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

The First Cambridge Conference on Advances in Treating Metastatic Bone Cancer, a symposium held in Cambridge, Massachusetts, October 28 to 29, 2005, Was convened to discuss recent advances and research related to the natural history of bone metastases and skeletal complications, bone cancer biology, treatment of myeloma and other solid tumors, and treatment-induced bone loss. The conference format combined brief presentations with extended periods of discussion. The conclusions reached during the 2-day meeting are summarized in this article and presented in more detail in the individual articles and accompanying discussion sessions that comprise the conference proceedings.

Original language	English (US)
Pages (from-to)	6209s-6212s
Journal	Clinical Cancer Research
Volume	12
Issue number	20 PART 2
DOIs	https://doi.org/10.1158/1078-0432.CCR-06-1213
State	Published - Oct 15 2006

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-06-1213

Cite this

Lipton, A., Berenson, J. R., Body, J. J., Boyce, B. F., Bruland, O. S., Carducci, M. A., Cleeland, C. S., Clohisy, D. R., Coleman, R. E., Cook, R. J., Guise, T. A., Pearse, R. N., Powles, T. J., Rogers, M. J., Roodman, G. D., Smith, M. R., Suva, L. J., Vessella, R. L., Weilbaecher, K. N., & King, L. (2006). Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference. Clinical Cancer Research, 12(20 PART 2), 6209s-6212s. https://doi.org/10.1158/1078-0432.CCR-06-1213

Lipton, A, Berenson, JR, Body, JJ, Boyce, BF, Bruland, OS, Carducci, MA, Cleeland, CS, Clohisy, DR, Coleman, RE, Cook, RJ, Guise, TA, Pearse, RN, Powles, TJ, Rogers, MJ, Roodman, GD, Smith, MR, Suva, LJ, Vessella, RL, Weilbaecher, KN & King, L 2006, 'Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference', Clinical Cancer Research, vol. 12, no. 20 PART 2, pp. 6209s-6212s. https://doi.org/10.1158/1078-0432.CCR-06-1213

@article{4490202e72e847b88867a939f11e35be,

title = "Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference",

abstract = "The First Cambridge Conference on Advances in Treating Metastatic Bone Cancer, a symposium held in Cambridge, Massachusetts, October 28 to 29, 2005, Was convened to discuss recent advances and research related to the natural history of bone metastases and skeletal complications, bone cancer biology, treatment of myeloma and other solid tumors, and treatment-induced bone loss. The conference format combined brief presentations with extended periods of discussion. The conclusions reached during the 2-day meeting are summarized in this article and presented in more detail in the individual articles and accompanying discussion sessions that comprise the conference proceedings.",

author = "Allan Lipton and Berenson, {James R.} and Body, {Jean Jacques} and Boyce, {Brendan F.} and Bruland, {Oyvind S.} and Carducci, {Michael A.} and Cleeland, {Charles S.} and Clohisy, {Denis R.} and Coleman, {Robert E.} and Cook, {Richard J.} and Guise, {Theresa A.} and Pearse, {Roger N.} and Powles, {Trevor J.} and Rogers, {Michael J.} and Roodman, {G. David} and Smith, {Matthew R.} and Suva, {Larry J.} and Vessella, {Robert L.} and Weilbaecher, {Katherine N.} and Laura King",

year = "2006",

month = oct,

day = "15",

doi = "10.1158/1078-0432.CCR-06-1213",

language = "English (US)",

volume = "12",

pages = "6209s--6212s",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "20 PART 2",

}

TY - JOUR

T1 - Advances in treating metastatic bone cancer

T2 - Summary statement for the First Cambridge Conference

AU - Lipton, Allan

AU - Berenson, James R.

AU - Body, Jean Jacques

AU - Boyce, Brendan F.

AU - Bruland, Oyvind S.

AU - Carducci, Michael A.

AU - Cleeland, Charles S.

AU - Clohisy, Denis R.

AU - Coleman, Robert E.

AU - Cook, Richard J.

AU - Guise, Theresa A.

AU - Pearse, Roger N.

AU - Powles, Trevor J.

AU - Rogers, Michael J.

AU - Roodman, G. David

AU - Smith, Matthew R.

AU - Suva, Larry J.

AU - Vessella, Robert L.

AU - Weilbaecher, Katherine N.

AU - King, Laura

PY - 2006/10/15

Y1 - 2006/10/15

N2 - The First Cambridge Conference on Advances in Treating Metastatic Bone Cancer, a symposium held in Cambridge, Massachusetts, October 28 to 29, 2005, Was convened to discuss recent advances and research related to the natural history of bone metastases and skeletal complications, bone cancer biology, treatment of myeloma and other solid tumors, and treatment-induced bone loss. The conference format combined brief presentations with extended periods of discussion. The conclusions reached during the 2-day meeting are summarized in this article and presented in more detail in the individual articles and accompanying discussion sessions that comprise the conference proceedings.

AB - The First Cambridge Conference on Advances in Treating Metastatic Bone Cancer, a symposium held in Cambridge, Massachusetts, October 28 to 29, 2005, Was convened to discuss recent advances and research related to the natural history of bone metastases and skeletal complications, bone cancer biology, treatment of myeloma and other solid tumors, and treatment-induced bone loss. The conference format combined brief presentations with extended periods of discussion. The conclusions reached during the 2-day meeting are summarized in this article and presented in more detail in the individual articles and accompanying discussion sessions that comprise the conference proceedings.

UR - http://www.scopus.com/inward/record.url?scp=33750684652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750684652&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-06-1213

DO - 10.1158/1078-0432.CCR-06-1213

M3 - Article

C2 - 17062702

AN - SCOPUS:33750684652

SN - 1078-0432

VL - 12

SP - 6209s-6212s

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 20 PART 2

ER -

Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this